Log In
Print
BCIQ
Print
Print this Print this
 

Oxigon (OX1, SHP622)

Also known as: VP20629

  Manage Alerts
Collapse Summary General Information
Company Intellect Neurosciences Inc.
DescriptionAntioxidant and anti-amyloid compound
Molecular Target Beta amyloid
Mechanism of ActionAntioxidant; Disrupts amyloid plaques
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationAtaxia
Indication DetailsTreat Friedreich's ataxia (FRDA)
Regulatory Designation

Partner

Shire plc


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today